TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM. - Hung, Alice L.; Maxwell, Russell; Belcaid, Zineb; Mathios, Dimitrios; Luksik, Andrew S.; Kim, Eileen; Wu, Adela; Xia, Yuanxuan; Garzon-Muvdi, Tomas; Jackson, Christopher; Ye, Xiaobu; Tyler, Betty; et al. (OncoImmunology, 2018)